Pharmafile Logo
Pharmafocus logo
Advanced Search

EUA granted to AstraZeneca’s antibody therapy for COVID-19 prevention

December 9, 2021
Business Services

AstraZeneca announced that its Evusheld antibody combination for the prevention of COVID-19 in immunocompromised adults and adolescents has been granted …

News

Abbott receives CE mark for traumatic brain injury blood test

December 8, 2021
Research and Development

Abbott has received a CE mark for its laboratory traumatic brain injury (TBI) blood test. This will be the first …

News
mat-napo-pij34zrzeew-unsplash

Positive Phase III trial results for plant-based COVID-19 vaccine candidate

December 8, 2021
Research and Development

The biopharmaceutical company Medicago, alongside GlaxoSmithKline, have announced positive efficacy and safety results from the global Phase III placebo-controlled efficacy …

News

Booster vaccines may be needed for ‘years to come’, says Pfizer

December 8, 2021
Research and Development

Ben Osborn, country manager for Pfizer in the UK, has shared that coronavirus booster jabs will likely be necessary “for …

News

WHO reject convalescent plasma treatment for COVID-19

December 7, 2021
Manufacturing and Production

WHO now strongly recommend against the use of convalescent plasma in the treatment of COVID-19 patients regardless of their stage …

News

Study reveals young people recover quickly from rare COVID-19 side effect

December 7, 2021
Manufacturing and Production

Most young people under the age of 21 who develop suspected COVID-19 myocarditis (inflammation of the muscle), show mild symptoms …

News

GSK antibody treatment effective against Omicron, study suggests

December 7, 2021
Manufacturing and Production

GlaxoSmithKline Plc have shared that research shows its antibody treatment is effective against the range of mutations in the recently-emerged …

News

Acadia Pharmaceuticals achieve positive Phase III results in Rett Syndrome trial

December 7, 2021
Manufacturing and Production

Acadia Pharmaceuticals have announced positive top-line results from the pivotal, Phase III Lavender study, which evaluated the efficacy and safety …

News

Maintaining product authenticity: The solution to a serial problem

December 6, 2021
Sales and Marketing

Counterfeit medicines pose a serious risk to public safety, and, in some cases, can lead to serious adverse effects (SAE) …

Feature

Sidelined or streamlined? Diabetic care and COVID-19

December 6, 2021
Sales and Marketing

The worldwide restrictions put in place as a result of COVID-19 have necessitated innovation in multiple medical spheres. Diabetes, which …

Feature

TIB Molbiol develops test kits for Omicron variant detection

December 6, 2021
Sales and Marketing

TIB Molbiol, a newly acquired subsidiary of Roche, has developed three new VirSNiP test kits for the detection of mutations …

News

FDA grants Lilly’s COVID-19 antibody therapy EUA for paediatric use

December 6, 2021
Sales and Marketing

Eli Lilly has been granted an expanded Emergency Use Authorisation (EUA) for its neutralising antibody treatment, based on the safety …

News

J&J COVID-19 booster shows increase in antibody and T-cell responses, in Phase II trial

December 6, 2021
Sales and Marketing

Johnson & Johnson have announced positive results from an independent Phase II study, which reveal that a booster shot of …

News

Omicron could become dominant variant in UK within weeks, expert warns

December 6, 2021
Research and Development

Infectious diseases expert, Professor Paul Hunter, has warned that Omicron could become the UK’s dominant COVID-19 variant within weeks.The UK …

News

UK study shows Pfizer and Moderna jabs give best COVID-19 protection

December 3, 2021
Medical Communications

The Pfizer and Moderna booster vaccines have been shown to provide the best overall boost response, according to a UK …

News

WHO say Delta measures will help fight Omicron

December 3, 2021
Medical Communications

WHO officials have shared that COVID-19 health measures taken prior to the emergence of Omicron will also help combat the …

News

Researchers develop blood test for HPV-associated head and neck cancer

December 3, 2021
Medical Communications

A new blood test developed by researchers at Mass Eye and Ear and Mass General Hospital have developed a more …

News

ARASENS Phase III trial for prostate cancer treatment meets primary endpoint

December 3, 2021
Medical Communications

Orion and Bayer’s Phase III ARASENS trial has demonstrated an increase in overall survival, evaluating darolutamide in combination with docetaxel …

News

QIAGEN announces CE marking of T-cell response measuring device

December 2, 2021
Business Services

QIAGEN has launched a CE-marked version of its QuantiFEROn SARS-CoV-2 assay, which measures T-cell responses to SARS-CoV-2, and aids in …

News

UK regulator approves antibody drug which may help tackle Omicron

December 2, 2021
Research and Development

UK drug regulators have approved Xevudy (sotrovimab), a new coronavirus antibody treatment made by GlaxoSmithKline (GSK), which has been found …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026